Examination of blood concentration change of each drug in patient-controlled analgesia with oxycodone ketamine lidocaine

Examination of blood concentration change of each drug in patient-controlled analgesia with oxycodone ketamine lidocaine - Correlation effects and blood levels of oxycodone, ketamine, lidocaine

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012569

Enrollment

Registered

2013-12-13

Start date

2013-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer pain

Interventions

Intravenous administration of oxycodone, ketamine, lidocaine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: At 20 years old or more, patients with cancer pain who are adaptive intravenous PCA with oxycodone injection

Exclusion criteria

Exclusion criteria: Patients using opioids at the time of recruitment Patients who can not use the PCA pump Patients with severe renal disease, severe liver disease, severe respiratory disease, severe heart disease Patients are allergic to oxycodone, lidocaine, ketamin Patients who are considered by the attending physician unsuitable for the present test

Design outcomes

Primary

Measure	Time frame
Correlation of oxycodone, ketamine, lidocaine blood concentrations and oxycodone, ketamine, lidocaine consumption	—

Countries

Japan

Contacts

Public ContactTetsuya Iijima

University of Yamanashi University of Yamanashi School of Medicine, Anesthesiology

tiijima@yamanashi.ac.jp0552-73-9690

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026